OpenVSafe by OpenVAERS
Search V-safe

Y7J-22812-42487

4 vaccinations 9 coded responses 50 check-ins 8 free-text entries 0 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
322 / FL
Registered
2021-04-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-15
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-16
    Registered in v-safe
  3. 2021-04-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-04-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2021-04-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-22
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-29
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-05-06
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-05-12
    Dose 2 — Pfizer-BioNTech
  13. 2021-05-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Decreased appetite, Dizziness, Lymphadenopathy — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Dizziness and feeling like I was going to pass out. Loss of appetite. Swollen neck glands.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-05-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Joint pains, Fatigue or tiredness
    Adult check-in
  16. 2021-05-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains
    Adult check-in
  17. 2021-05-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  18. 2021-05-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  19. 2021-05-19
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-05-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-06-02
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-06-09
    Survey response — day 28, dose 2
    MedDRA: Arthralgia — Feeling: Fair
    Free text: All over body joint pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-06-16
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-06-23
    Survey response — day 42, dose 2
    MedDRA: Arthralgia — Feeling: Fair
    Free text: Continuing sore joints: wrists, ankles
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-08-13
    Survey response — 3 months, dose 2
    MedDRA: Nasal congestion — Feeling: Good
    Free text: Nasal congestion
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  26. 2021-11-11
    Survey response — 6 months, dose 2
    MedDRA: Catheterisation cardiac, Stress cardiomyopathy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: In August I had what seemed to be a possible heart attack but was diagnosed through a cardiac catheterization as Takotsubos cardiomyopathy.
    MedDRA releases: 2024-11 · check-in free text available
  27. 2021-11-11
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · Hospitalization · no matching call case
  28. 2021-12-07
    Dose 3 — Pfizer-BioNTech
  29. 2021-12-08
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness, Hypotension, Vaccine positive rechallenge — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Very low blood pressure last night and this morning. Felt faint because of of the low blood pressure. This happened after my second shot as well.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-12-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches · Be unable to do your normal daily activities
    Adult check-in
  31. 2021-12-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  32. 2021-12-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  33. 2021-12-12
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  34. 2021-12-13
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-12-14
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-12-21
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-12-28
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-01-04
    Survey response — day 28, dose 3
    MedDRA: Fatigue, Headache, Rhinorrhoea — Feeling: Fair
    Free text: Headache, runny nose, fatigue
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-01-11
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-01-18
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-03-08
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-06-07
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  43. 2022-07-15
    Dose 4 — Pfizer-BioNTech
  44. 2022-07-16
    Survey response — days 1–6 daily, dose 4
    MedDRA: Dizziness — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Faintness
    MedDRA releases: 2024-11 · check-in free text available
  45. 2022-07-17
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Nausea · Be unable to do your normal daily activities
    Adult check-in
  46. 2022-07-18
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · Fever · Joint pains
    Adult check-in
  47. 2022-07-19
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain, Itching · Joint pains
    Adult check-in
  48. 2022-07-20
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in
  49. 2022-07-21
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  50. 2022-07-22
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  51. 2022-07-29
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  52. 2022-08-05
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  53. 2022-08-12
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  54. 2022-08-26
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  55. 2022-10-14
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  56. 2023-01-13
    Survey response — 6 months, dose 4
    MedDRA: Fatigue, Pain, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-04-15Pfizer-BioNTech
22021-05-12Pfizer-BioNTech
32021-12-07Pfizer-BioNTech No
42022-07-15Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome

1 report(s) with no call case — see the timeline.

Free text

Release 8 — days 1–6 daily, dose 2

2021-05-13

Systemic reaction (other): Dizziness and feeling like I was going to pass out. Loss of appetite. Swollen neck glands.

Release 9 — day 28, dose 2

2021-06-09

Symptoms: All over body joint pain

Release 9 — day 42, dose 2

2021-06-23

Symptoms: Continuing sore joints: wrists, ankles

Release 9 — 3 months, dose 2

2021-08-13

Symptoms: Nasal congestion

Release 10 — 6 months, dose 2

2021-11-11

Symptoms: In August I had what seemed to be a possible heart attack but was diagnosed through a cardiac catheterization as Takotsubos cardiomyopathy.

Release 10 — days 1–6 daily, dose 3

2021-12-08

Systemic reaction (other): Very low blood pressure last night and this morning. Felt faint because of of the low blood pressure. This happened after my second shot as well.

Release 10 — day 28, dose 3

2022-01-04

Symptoms: Headache, runny nose, fatigue

Release 12 — days 1–6 daily, dose 4

2022-07-16

Systemic reaction (other): Faintness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ ✓ ✓
SDCatheterisation cardiac · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDNasal congestion ✓ · ✓
SDPain · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SDSARS-CoV-2 test negative · · ✓
SDSARS-CoV-2 test positive · · ✓
SDStress cardiomyopathy · · ✓
SRODecreased appetite ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROHypotension · · ✓
SROLymphadenopathy ✓ ✓ ✓
SROVaccine positive rechallenge · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release